Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "physician"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
Search alternatives
:
"physician" »
"physicians"
,
"physical"
Showing
1
-
20
of
62
Search:
'"physician"'
,
query time: 0.08s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis
Published 2018
CADTH
“
...
physician
with experience in the diagnosis and management of GCA. A reduction in price...
”
Read Now
2
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (Orfadin -- Sobi Canada Inc.) : indication: the treatment of adult and pediatric patients with hereditary tyrosinemi...
Published 2018
CADTH
“
... is prescribed by a
physician
with experience in the diagnosis and management of hereditary tyrosinemia type-1...
”
Read Now
3
Lifestyle prescriptions : a review of the clinical evidence
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
... for the clinical effectiveness of formal PA prescriptions issued by a
physician
or nurse practitioner...
”
Read Now
4
Lifestyle prescriptions : a review of the clinical evidence
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
... for the clinical effectiveness of formal PA prescriptions issued by a
physician
or nurse practitioner...
”
Read Now
5
CADTH Canadian Drug Expert Committee recommendation: Apomorphine hydrochloride (Movapo -- Paladin Labs Inc.) : indication : Parkinson's disease
Published 2018
CADTH
“
...
physician
with experience in the diagnosis and management of PD. Reduction in price...
”
Read Now
6
CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis
Published 2018
CADTH
“
...
physician
with experience in the diagnosis and management of GCA. A reduction in price...
”
Read Now
7
Disposable, non-sterile gloves for minor surgical procedures : a review of clinical evidence
by
Ho, Chuong
,
Adams, Alison
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
... in healthcare settings such as
physician
offices, dental offices or emergent care settings. Despite...
”
Read Now
8
CADTH Canadian drug expert committee recommendation: Lanadelumab (Takhzyro -- shire pharma Canada ULC) : indication: for the routine prevention of attacks of hereditary angioedema...
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
.... The diagnosis of HAE type I or II is made by a specialist
physician
who has experience in the diagnosis of HAE...
”
Read Now
9
CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... in patients with disease activity, based on the
physician
assessment...
”
Read Now
10
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (Orfadin -- Sobi Canada Inc.) : indication: the treatment of adult and pediatric patients with hereditary tyrosinemi...
Published 2018
CADTH
“
... is prescribed by a
physician
with experience in the diagnosis and management of hereditary tyrosinemia type-1...
”
Read Now
11
Disposable, non-sterile gloves for minor surgical procedures : a review of clinical evidence
by
Ho, Chuong
,
Adams, Alison
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
... in healthcare settings such as
physician
offices, dental offices or emergent care settings. Despite...
”
Read Now
12
CADTH Canadian drug expert committee recommendation: Lanadelumab (Takhzyro -- shire pharma Canada ULC) : indication: for the routine prevention of attacks of hereditary angioedema...
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
.... The diagnosis of HAE type I or II is made by a specialist
physician
who has experience in the diagnosis of HAE...
”
Read Now
13
Omalizumab (Xolair)
Published 2017
CADTH
“
...) visits, or
physician
visits; a dearth of data for patients who fail treatment with a long-acting beta2...
”
Read Now
14
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (MDK-Nitisinone -- mendeliKABs inc.) : indication : the treatment of adult and pediatric patients with hereditary ty...
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
... in patients with an established diagnosis of HT-1. The drug is prescribed by a
physician
with experience...
”
Read Now
15
CADTH Canadian Drug Expert Committee recommendation: Apomorphine hydrochloride (Movapo -- Paladin Labs Inc.) : indication : Parkinson's disease
Published 2018
CADTH
“
...
physician
with experience in the diagnosis and management of PD. Reduction in price...
”
Read Now
16
CADTH Canadian Drug Expert Committee recommendation: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi -- Gilead Sciences Canada, Inc.) : indication : chronic hepatitis C virus infection
Published 2018
CADTH
“
...
physician
with experience in the diagnosis and management of HCV infection. Drug plan cost for SOF/VEL/VOX...
”
Read Now
17
Omalizumab (Xolair)
Published 2017
CADTH
“
...) visits, or
physician
visits; a dearth of data for patients who fail treatment with a long-acting beta2...
”
Read Now
18
CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... in patients with disease activity, based on the
physician
assessment...
”
Read Now
19
CADTH Canadian drug expert committee recommendation: Cyclosporine 0.1% (Verkazia -- Santen Canada Inc.) : indication : treatment of severe vernal keratoconjunctivitis in children f...
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
... scale. 3. Severity of signs and symptoms of VKC should be documented by the treating
physician
...
”
Read Now
20
Group care for chronic disease management : review of the clinical effectiveness, cost-effectiveness, and guidelines
Published 2013
Canadian Agency for Drugs and Technologies in Health
“
... is provided by a multidisciplinary team comprising of members such as
physician
, specialist, nurse, dietitian...
”
1
2
3
4
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Year of Publication
From:
To:
Classification
610 - Medicine & health
46
330 - Economics
16
140 - Specific philosophical schools
6
700 - The arts; fine & decorative arts
4
000 - Computer science, information & general works
2
100 - Philosophy & psychology
2
more ...
612 - Human physiology
2
410 - Linguistics
1
see all ...
less ...
Language
English
62
Collection
National Center for Biotechnology Information
62
Author
Canadian Agency for Drugs and Technologies in Health
CADTH Canadian Drug Expert Committee
15
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
10
Crain, Janet
4
Raj, Michael
4
Ho, Chuong
3
more ...
Adams, Alison
2
Brooker, Ann-Sylvia
2
Chen, Stella
2
Garland, Sarah
2
Jones, Sarah
2
Kaunelis, David
2
Loshak, Hannah
2
MacPherson, Jennifer
2
Pitre, Elizabeth
2
Singh, Kavita
2
Singh, Subhkir
2
Cimon, Karen
1
Farrah, Kelly
1
Lau, Andrea
1
see all ...
less ...
Recently Uploaded
Last Month
5
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&lookfor=%22physician%22&type=AllFields
Send by Email
×
Loading...